These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 13738700)

  • 1. The assay and properties of labile factor (factor V).
    QUICK AJ
    J Clin Pathol; 1960 Nov; 13(6):457-62. PubMed ID: 13738700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemical state of the calcium reacting in the coagulation of blood.
    QUICK AJ; STEFANINI M
    J Gen Physiol; 1948 Nov; 32(2):191-202. PubMed ID: 18891145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "In vitro" correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrate.
    Bulato C; Novembrino C; Anzoletti MB; Spiezia L; Gavasso S; Berbenni C; Tagariello G; Farina C; Nardini I; Campello E; Peyvandi F; Simioni P
    Haemophilia; 2018 Jul; 24(4):648-656. PubMed ID: 29578313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of time and temperature on coagulation analytes in stored plasma.
    Heil W; Grunewald R; Amend M; Heins M
    Clin Chem Lab Med; 1998 Jun; 36(7):459-62. PubMed ID: 9746270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
    Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underestimation of plasma level of factor V coagulant activity and fibrinogen concentration together with prolonged prothrombin time, activated partial thromboplastin time and thrombin time can result from pre-analytical very low calcium level in citrated sample tube.
    d'Audigier C; Delassasseigne C; Robert A; Eschwège V
    Int J Lab Hematol; 2016 Feb; 38(1):50-3. PubMed ID: 26406495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a high-fat diet on the concentration of antihemophilic globulin and factor V.
    TEITELBAUM JI; COOPERBERG AA; KALANT N
    Can Med Assoc J; 1962 Nov; 87(19):1001-4. PubMed ID: 13980471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between secretion of platelet Factor 4 and thrombin generation during in vitro blood clotting.
    Shuman MA; Levine SP
    J Clin Invest; 1980 Feb; 65(2):307-13. PubMed ID: 6243308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood coagulation in fish.
    Doolittle RF; Surgenor DM
    Am J Physiol; 1962 Nov; 203():964-70. PubMed ID: 22103034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin.
    Ofosu FA; Sie P; Modi GJ; Fernandez F; Buchanan MR; Blajchman MA; Boneu B; Hirsh J
    Biochem J; 1987 Apr; 243(2):579-88. PubMed ID: 2443128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro hemostatic properties of French lyophilized plasma.
    Martinaud C; Civadier C; Ausset S; Verret C; Deshayes AV; Sailliol A
    Anesthesiology; 2012 Aug; 117(2):339-46. PubMed ID: 22739764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of hepes buffer on clotting tests, assay of factors V and VIII and on the hydrolysis of esters by thrombin and thrombokinase.
    Roberts PS; Hughes HN; Fleming PB
    Thromb Haemost; 1976 Feb; 35(1):202-10. PubMed ID: 989187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE ACTIVATION OF PROACCELERIN.
    DE BERGSAGEL DE; NOCKOLDS ER
    Br J Haematol; 1965 Jul; 11():395-410. PubMed ID: 14317432
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of the physiological blood clotting process on the coagulation of blood by staphylocoagulase.
    TAGER M; LODGE AL
    J Exp Med; 1951 Jul; 94(1):73-85. PubMed ID: 14850637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic aspects of blood clotting: thrombokinase and cofactors in the conversion of prothrombin to thrombin.
    Ferguson JH; Ennis EG; Latridis PG; White NB
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):647-63. PubMed ID: 5590251
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasmin-induced procoagulant effects in the blood coagulation: a crucial role of coagulation factors V and VIII.
    Ogiwara K; Nogami K; Nishiya K; Shima M
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):568-76. PubMed ID: 20625277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin generation, ProC(®)Global, prothrombin time and activated partial thromboplastin time in thawed plasma stored for seven days and after methylene blue/light pathogen inactivation.
    Thiele T; Hron G; Kellner S; Wasner C; Westphal A; Warkentin TE; Greinacher A; Selleng K
    Blood Transfus; 2016 Jan; 14(1):66-72. PubMed ID: 26192785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom.
    Monteiro RQ; Zingali RB
    Arch Biochem Biophys; 2000 Oct; 382(1):123-8. PubMed ID: 11051105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FUNCTION OF AC-GLOBULIN AND LIPID IN BLOOD CLOTTING.
    SEEGERS WH; COLE ER; AOKI N
    Can J Biochem Physiol; 1963 Dec; 41():2441-61. PubMed ID: 14099702
    [No Abstract]   [Full Text] [Related]  

  • 20. ENZYME THEORY OF BLOOD CLOTTING.
    SEEGERS WH
    Fed Proc; 1964; 23():749-56. PubMed ID: 14195458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.